Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $549.00

Intuitive Surgical (NASDAQ:ISRG) had its price target hoisted by Wells Fargo & Company from $466.00 to $549.00 in a research note released on Friday, Benzinga reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock.

Several other research firms also recently weighed in on ISRG. Mizuho lifted their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday. Raymond James increased their target price on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Stifel Nicolaus upped their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Stock Up 10.0 %

ISRG opened at $521.15 on Friday. The business has a fifty day simple moving average of $483.85 and a 200-day simple moving average of $438.56. The firm has a market cap of $184.85 billion, a PE ratio of 94.07, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a fifty-two week low of $254.85 and a fifty-two week high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. Intuitive Surgical’s revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the business posted $1.18 EPS. On average, equities research analysts anticipate that Intuitive Surgical will post 5.22 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, SVP Henry L. Charlton sold 40,243 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $5,441,507.50. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 53,120 shares of company stock valued at $25,528,753. Insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several large investors have recently modified their holdings of the company. NBC Securities Inc. lifted its position in Intuitive Surgical by 34.4% during the 1st quarter. NBC Securities Inc. now owns 121 shares of the medical equipment provider’s stock worth $48,000 after acquiring an additional 31 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of Intuitive Surgical by 7.8% in the first quarter. Massmutual Trust Co. FSB ADV now owns 930 shares of the medical equipment provider’s stock worth $371,000 after purchasing an additional 67 shares during the period. Signal Advisors Wealth LLC bought a new position in shares of Intuitive Surgical in the first quarter worth about $203,000. &PARTNERS acquired a new position in shares of Intuitive Surgical during the 1st quarter worth about $293,000. Finally, International Assets Investment Management LLC boosted its stake in Intuitive Surgical by 9.7% during the 1st quarter. International Assets Investment Management LLC now owns 2,234 shares of the medical equipment provider’s stock valued at $882,000 after purchasing an additional 198 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.